REDWOOD CITY, Calif.--(BUSINESS WIRE)--iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final clearance from the U.S. Food and Drug Administration (FDA) for ...

In this interview, News-Medical talks to Professor Gilberto Gonzalez about using a common imaging technique to decide on the best course of treatment for large vessel occlusion stroke patients, ...

According to a study published in the American Journal of Roentgenology, patients discharged from the emergency department (ED) after CT with CTA alone could have benefitted from an alternative or ...

SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first ...

Cerebrovasular imaging company iSchemaView has received the FDA nod for its latest product the RAPID CTA, a 3D imaging platform for computed tomogrpahy angiography (CTA). “Our goal is to provide ...

Please provide your email address to receive an email when new articles are posted on . Using coronary CTA for comprehensive anatomic interpretation was superior to functional imaging to determine ...

GRAPEVINE, TX—The adoption of high-sensitivity troponin testing will likely affect which patients receive cardiac CT angiography (CTA) in the emergency department (ED), but whether CTA’s use then goes ...

SPONSORED: Dr. Mulkareddy, a distinguished cardiologist with Prairie Cardiovascular in O’Fallon, Illinois, explains the importance of early detection and how coronary CTA is revolutionizing heart care ...

Editor's Note: Ricardo C. Cury, MD (Miami Cardiac and Vascular Institute, Radiology Associates of South Florida), a noninvasive cardiovascular radiologist and past president of the Society of ...

Cleerly Coronary, a company that uses A.I powered imaging to analyze heart scans, announced a $43 million Series B funding this week. The funding comes at a moment when it seems that a new way of ...